Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction

[1] Sengupta K(2012)Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study Lipids Health Dis 11 11-122

[2] Mishra AT(2004)Obesity: an overview on its current perspectives and treatment options Nutr J 3 3-49

[3] Rao MK(1998)Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves Am J Clin Nutr 67 44-410

[4] Sarma KV(2001)Pharmacological treatment of obesity in paediatric patients Paediatr Drugs 3 405-2012

[5] Krishnaraju AV(2005)Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment Circulation 111 1999-541

[6] Trimurtulu G(1993)Primary pulmonary hypertension and fenfluramine use Br Heart J 70 537-1873

[7] Nammi S(2013)Emerging approaches for the treatment of hypertriglyceridemia Expert Opin Pharmacother 14 1869-S42

[8] Koka S(1993)Dietary composition, substrate balances and body fat in subjects with a predisposition to obesity Int J Obes Relat Metab Disord 17 S41-49

[9] Chinnala KM(2001)A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble Chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals J Am Nutraceut Assoc 4 42-381

[10] Boini KM(2015)Isolation of chitosan from Ganoderma lucidum mushroom for biomedical applications J Mater Sci Mater Med 26 135-1156

[1] Sengupta K(2012)Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study Lipids Health Dis 11 11-122

[2] Mishra AT(2004)Obesity: an overview on its current perspectives and treatment options Nutr J 3 3-49

[3] Rao MK(1998)Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves Am J Clin Nutr 67 44-410

[4] Sarma KV(2001)Pharmacological treatment of obesity in paediatric patients Paediatr Drugs 3 405-2012

[5] Krishnaraju AV(2005)Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment Circulation 111 1999-541

[6] Trimurtulu G(1993)Primary pulmonary hypertension and fenfluramine use Br Heart J 70 537-1873

[7] Nammi S(2013)Emerging approaches for the treatment of hypertriglyceridemia Expert Opin Pharmacother 14 1869-S42

[8] Koka S(1993)Dietary composition, substrate balances and body fat in subjects with a predisposition to obesity Int J Obes Relat Metab Disord 17 S41-49

[9] Chinnala KM(2001)A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble Chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals J Am Nutraceut Assoc 4 42-381

[10] Boini KM(2015)Isolation of chitosan from Ganoderma lucidum mushroom for biomedical applications J Mater Sci Mater Med 26 135-1156